Galectin Therapeutics
GALT
#8074
Rank
S$0.22 B
Marketcap
$3.58
Share price
1.48%
Change (1 day)
36.57%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.14 B

According to Galectin Therapeutics's latest financial reports the company's total liabilities are S$0.14 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$71.69 M35.58%
2021-12-31S$52.87 M639.76%
2020-12-31S$7.14 M85.09%
2019-12-31S$3.86 M34.49%
2018-12-31S$2.87 M-27.66%
2017-12-31S$3.96 M-27.44%
2016-12-31S$5.47 M184.13%
2015-12-31S$1.92 M-14.43%
2014-12-31S$2.25 M-28.57%
2013-12-31S$3.15 M56.59%
2012-12-31S$2.01 M-29.87%
2011-12-31S$2.86 M-72.16%
2010-12-31S$10.3 M49.52%
2009-12-31S$6.89 M308.48%
2008-12-31S$1.68 M-75.21%
2007-12-31S$6.8 M-30.5%
2006-12-31S$9.79 M326.11%
2005-12-31S$2.29 M55.05%
2004-12-31S$1.48 M130.35%
2003-12-31S$0.64 M-44.4%
2002-12-31S$1.15 M13.49%
2001-12-31S$1.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$0.23 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.87 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA